Search Tag: cardiovascular disease
2024 13 Nov
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death with persistent disparities across social and demographic groups, including race and income. Recent research has focused on understanding cardiovascular risks and outcomes among marginalised populations, particularly sexual minorities (e.g., lesbian, gay, bisexual [LGB] adults),...Read more
2024 21 Oct
Sepsis affects nearly 50 million people globally. Survivors face significant long-term issues like reduced quality of life and frequent hospital readmissions. Studies show that 21.4% of survivors are readmitted within 30 days and 39% by one year, with sepsis-related readmissions being costlier than those for other conditions like heart failure or myocardial...Read more
2024 07 Oct
The primary goal of COVID-19 vaccination is to reduce the risk of infection, complications, and fatalities. However, the vaccine may also pose a small risk for certain cardiovascular events. The European Medicines Agency has identified myocarditis and pericarditis as very rare adverse effects (fewer than 1 in 10,000 cases) following mRNA vaccination...Read more
2024 30 Sep
A study using clinical trial data has identified a higher risk of stroke, heart attack, and hospitalisations for heart failure among older cancer survivors. Published in Cancer, the analysis also linked chemotherapy to increased rates of these cardiovascular conditions. While advancements in cancer treatments have reduced mortality rates over...Read more
2024 23 Sep
A study conducted at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Spain, has provided vital insights into how cardiometabolic risk factors and subclinical atherosclerosis affect the network of microvessels supplying the heart in asymptomatic, middle-aged individuals. The study is published in JACC: Cardiovascular Imaging. ...Read more
2024 01 Sep
A pooled analysis of three major trials presented at #ESCCongress2024 did not show significant reductions in cardiovascular death with finerenone. However, significant decreases in all-cause mortality, cardiovascular events, and kidney outcomes were observed. Cardiovascular diseases, chronic kidney disease (CKD), and metabolic conditions...Read more
2024 06 Aug
According to a new study, higher levels of urinary metals such as cadmium, tungsten, uranium, cobalt, copper, and zinc are associated with increased cardiovascular disease (CVD) and mortality. While previous research has documented the link between certain metals and CVD, this study expands the evidence to include a broader range of metals beyond arsenic,...Read more
2024 10 Jul
Since 1990, the prevalence of obesity among children and adolescents (as measured by body mass index, BMI) has increased fourfold, while obesity rates among adults have more than doubled. This trend in the obesity epidemic is expected to elevate the risk of BMI-associated diseases, particularly cardiovascular diseases and type 2 diabetes. ...Read more
2024 02 Jul
Implementing patient-centred palliative care therapies, including prescribing, adjusting, or discontinuing medications as needed, may help control symptoms and improve the quality of life for people with heart disease, according to a new scientific statement from the American Heart Association. The statement reviews current evidence on the...Read more
2024 12 Jun
In a new study, researchers at the Icahn School of Medicine at Mount Sinai have identified coding variants in 17 genes that provide new insights into the molecular basis of coronary artery disease (CAD). The team used an advanced artificial intelligence tool to make these discoveries. Their findings are published in Nature Genetics. The...Read more
2024 07 Jun
A study presented at the American College of Cardiology’s Care of the Athletic Heart conference shows that a substantial portion of young athletes are at risk for hypertension. Hypertension, or high blood pressure, affects 47% of adults in the U.S. Over time, this condition can weaken the heart, blood vessels, and kidneys, leading to the...Read more
2024 05 Jun
Driven by an ageing and increasingly diverse population, along with a significant rise in risk factors such as high blood pressure and obesity, the total costs related to cardiovascular disease (CVD) are projected to triple by 2050. This projection comes from the American Heart Association. It is expected that at least 61% of U.S. adults, or over...Read more
2024 02 Jun
People under 50 face a higher risk of heart attack or stroke if they’ve lived with obesity for 10 years, according to research presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Massachusetts. People with excess weight at any point in time have a greater risk of heart attacks and strokes. However, whether the duration...Read more
2024 01 Jun
Numerous studies have reported the health benefits of the Mediterranean diet. However, long-term data on its effects have been limited, and the reasons behind its mortality risk reduction are not well understood. In a new study following over 25,000 initially healthy women in the U.S. for up to 25 years, researchers from Brigham and Women’s Hospital...Read more
2024 28 May
Recent research indicates that heart failure induces a lasting stress memory in the body, potentially contributing to recurrent heart failure and other health issues. This memory involves changes to the DNA modifications of haematopoietic stem cells, which are crucial for producing immune cells like macrophages that protect heart health. During...Read more
2024 22 May
Obesity prevalence has steadily risen, affecting over 40% of U.S. adults aged 20 and older. Scientific advances have illuminated the multifaceted causes of obesity, including sociological and physiological factors. Treatment strategies now encompass lifestyle modifications, medications, and bariatric surgery, each posing unique implementation challenges....Read more
2024 14 May
According to a new study by researchers at Brigham and Women’s Hospital and Duke University School of Medicine, a genetic variant carried by 3-4% of self-identified Black Americans increases the risk of heart failure and death, leading to a significant decrease in population longevity. While the association between the V142I variant and...Read more
2024 13 Feb
An innovative initiative utilising artificial intelligence (AI) to tailor therapies for patients with cardiovascular disease was kicked off at a meeting in Utrecht, the Netherlands. Funded by €7.6 million from the EU's Horizon Europe programme, the NextGen project will be executed by a 21-member consortium, including the European Society...Read more
2024 13 Feb
An innovative initiative utilising artificial intelligence (AI) to tailor therapies for patients with cardiovascular disease was kicked off at a meeting in Utrecht, the Netherlands. Funded by €7.6 million from the EU's Horizon Europe programme, the NextGen project will be executed by a 21-member consortium, including the European Society...Read more
2024 07 Feb
Findings of the World Heart Report 2023 offer a comprehensive overview of cardiovascular health dimensions, trends and the current landscape. Drawing from epidemiological, policy, and economic data, the report is a valuable resource for national and international policymakers in identifying and addressing critical cardiovascular health priorities....Read more
2024 30 Jan
Over half of the U.S. population (51%) remains unaware that heart disease is the leading cause of death, as per a recent Harris Poll survey conducted by the American Heart Association. This lack of awareness persists despite heart disease maintaining its status as the number one killer for over a century. Heart Disease and Stroke Statistics report...Read more
2023 11 Oct
A new American Heart Association presidential advisory is reshaping the landscape of cardiovascular disease (CVD) by redefining risk, prevention, and management. This transformation is spurred by the recognition of the interplay between cardiovascular disease, kidney disease, Type 2 diabetes, and obesity, collectively termed cardiovascular-kidney-metabolic...Read more
2023 29 Sep
Much has changed since the introduction of the charter sixteen years ago; Europe needs a new plan of action that goes beyond health considerations — one fit for 2023 and beyond. Cardiovascular disease (CVD) is the leading cause of death globally and costs the EU economy 282 billion euros per year. The European Heart Health Charter, launched...Read more
2023 26 Aug
New research presented at the ESC Congress 2023 reveals that cardiovascular disease (CVD) costs the European Union (EU) an estimated €282 billion in 2021. The analysis was a collaborative study by the European Society of Cardiology (ESC) and the University of Oxford, UK. This figure highlights the significant impact of CVD on the region. ...Read more
2023 16 Aug
The biggest cardiovascular scientific event of the year - ESC Congress 2023, begins soon! Onsite in Amsterdam and online: 25 to 28 August 2023 There will be nine Hot Line Press Conferences, offering an initial glimpse into the findings of 30 significant studies in cardiovascular disease, along with the opportunity to engage with the researchers...Read more
2023 14 Aug
The American Heart Association, a global force for healthier lives for all announced its co-chairs for the 20 th anniversary of the Metro Chicago Go Red for Women® movement. Two executive leaders at GE HealthCare – Catherine Estrampes, president and CEO, U.S. and Canada, and Andrew DeLaO, chief strategy and marketing officer, U.S. and Canada – will...Read more
2023 22 Jul
Cardiovascular disease remains a major worldwide public health problem and despite significant advances in diagnosis and treatment, coronary artery disease represents the leading cause of death in the developed world. In some specific patient populations, such as including subjects with asymptomatic CAD, diabetes mellitus, obesity, and kidney or...Read more